Study of stroke types and thrombolysis treatment
Part of Brain & nervous system, Heart & circulation clinical trials.
This study includes people who have had certain kinds of sudden brain blood-flow problems (like an ischemic stroke, bleeding in the brain, or a brief warning episode) or conditions that look similar. It looks at how treatment such as clot-busting medicine (thrombolysis) fits for these situations.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a recent episode involving blood flow to the brain, such as an ischemic stroke (clot-related), brain bleeding, or a transient ischemic attack (TIA, a brief warning episode).
- Your symptoms may also be a “stroke mimic” (something else that can look like a stroke).
- You are being evaluated/treated for one of the conditions listed above.
- There are no listed exclusion rules in the provided criteria.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at inflammatory cells in the blood and the blood clot removed from the brain during a stroke emergency. The goal is to better understand the role of inflammation in stroke, which could lead to improved treatments.
This study looks at the composition of a stroke blood clot and compares it with blood test results to understand treatment response, stroke cause, and prognosis. It may help doctors better predict outcomes and improve care after ischemic stroke.
This trial tests if a procedure to remove a large blood clot from the brain (called a thrombectomy) can help people with severe strokes who have a large damaged area. It is for people who can be treated within 24 hours of their stroke starting.
This study looks at people who have had an ischemic stroke (a type caused by a blocked blood vessel). It is collecting information over time to better understand care needs and follow-up after stroke.
This study records outcomes for people having an acute ischemic stroke treated with an endovascular (catheter-based) procedure. It may help doctors understand how clot-removal treatment works in different patients and hospitals.
This study records information from adults with an acute ischemic stroke (a stroke caused by a blocked artery) who receive clot-busting medicine within 4.5 hours. It may help doctors better understand which patients benefit from treatment and how care decisions are made for certain blocked brain arteries.
Hear when a new Stroke, Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.